COMMUNIQUÉS West-GlobeNewswire

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
16/09/2024
BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies for patients with solid tumors, [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
16/09/2024
BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases [...]
Galapagos receives transparency notification from EcoR1 Capital
16/09/2024
Mechelen, Belgium; 16 September 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from EcoR1 Capital LLC. Pursuant to Belgian transparency [...]
ImmuneSensor Therapeutics to Participate in the UBS 2024 Virtual Biotechnology Private Company Symposium
16/09/2024
DALLAS, Sept. 16, 2024 (GLOBE NEWSWIRE) -- ImmuneSensor Therapeutics, a clinical-stage biotherapeutics company focused on the development of first- and best-in-class inhibitors and agonists targeting the cGAS-STING [...]
KFSHRC Redefines Global Healthcare with AI and Robotic Surgery Innovations
16/09/2024
RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) leads healthcare innovation, leveraging AI-driven patient management, remote diagnostics, and [...]
KFSHRC Deputy CEO Receives Global Innovative Healthcare & Impact Transformation Award at New York Summit
16/09/2024
RIYADH, Saudi Arabia, Sept. 16, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) Deputy Chief Executive Officer Dr. Björn Zoéga has been awarded the prestigious 2024 C3 Global [...]
Sanofi: Information concerning the total number of voting rights and shares - August 2024
16/09/2024
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions - AOUT 2024
16/09/2024
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Props.Cash Bolsters Responsible Gaming Offering with Birches Health Partnership
16/09/2024
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Leading sports gaming research platform Props.Cash is expanding its responsible gaming efforts by partnering with Birches Health, a national provider of gaming education [...]
Kairos Pharma Prices $6.2 Million Initial Public Offering
16/09/2024
Company anticipates commencement of trading on the NYSE American effective September 16, 2024 under the symbol “KAPA” LOS ANGELES, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
16/09/2024
Please see enclosed pdf. Attachment 16092024_trading_in_shares_KV
Impact BioMedical Inc. Announces Pricing of Initial Public Offering
16/09/2024
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing of its initial [...]
Capsa Healthcare’s New Interactive Website Assists Healthcare Leaders in Technology Decision Making
16/09/2024
COLUMBUS, Ohio, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare , a pioneer in health IT, medication management, and pharmacy automation, today announced the launch of a new interactive website designed to help [...]
Trading by management and close relations of management
16/09/2024
Please read the full announcement in PDF Attachment 2024_37_Trading_By_Management
L’association RYBREVANT®▼ (amivantamab) plus chimiothérapie démontre un taux de réponse globale de 49 pour cent dans le cancer colorectal métastatique
16/09/2024
La durée médiane de la réponse atteint 7,4 mois avec le traitement combiné chez les patients atteints d’une forme agressive de la maladie 1 De nouveaux résultats démontrent l’efficacité de l’amivantamab au-delà du [...]
ARC Fertility Sponsors Purchaser Business Group on Health 2024 Maternal Health and Birth Equity Summit
16/09/2024
CUPERTINO, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ARC Fertility (ARC), a highly experienced national provider of innovative fertility and family-forming benefits for employers and their employees, is pleased to [...]
RYBREVANT®▼ (amivantamab) associé à une chimiothérapie montre une tendance de survie globale positive par rapport à la chimiothérapie chez les patients atteints d'un cancer du poumon muté par EGFR préalablement traité
16/09/2024
Les résultats suite à la progression ont mis en évidence une amélioration significative et durable pour l'amivantamab plus chimiothérapie par rapport à la chimiothérapie seule 1 BEERSE, BELGIQUE, 16 sept. 2024 (GLOBE [...]
WellRithms Featured for Fourth Consecutive Year on Portland Business Journal List of Fastest-Growing Private Companies
16/09/2024
PORTLAND, Ore., Sept. 16, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, announces the Company’s fourth consecutive year of recognition from the Portland Business Journal as one of [...]
Thought Leadership & Innovation Foundation Announces Gala to Initiate Development of Patient Portal for Age-Related Macular Degeneration
16/09/2024
Howard Fine, MD Delivers Keynote MCLEAN, Va., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and [...]

Pages